This is not the most recent version of the article. View current version (7 OCT 2009)

Intervention Protocol

Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease

  1. Louisa Ng1,*,
  2. Fary Khan2,
  3. Susan Mathers3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 22 APR 2008

DOI: 10.1002/14651858.CD007425


How to Cite

Ng L, Khan F, Mathers S. Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007425. DOI: 10.1002/14651858.CD007425.

Author Information

  1. 1

    Royal Melbourne Hospital, Royal Park Campus, Rehabilitation, Parkville, Victoria, Australia

  2. 2

    University of Melbourne, Department of Rehabilitation Medicine, Melbourne, Victoria, Australia

  3. 3

    Calvary Health Care Bethlem Limited, Neurology, Caulfield, Victoria, Australia

*Louisa Ng, Rehabilitation, Royal Melbourne Hospital, Royal Park Campus, Poplar Road, Parkville, Victoria, 3052, Australia. louisa.ng@mh.org.au.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 8 OCT 2008

SEARCH

This is not the most recent version of the article. View current version (07 OCT 2009)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effectiveness of multidisciplinary care in adults with motor neuron disease/amyotrophic lateral sclerosis (MND or ALS).  To specifically explore the following areas:

  • Does organised multidisciplinary care achieve better outcomes than the absence of such services in persons with MND and their caregivers, or both?
  • Which type of programmes are effective and in which setting?
  • Does a greater intensity (time and/or expertise) of rehabilitation lead to greater gains?
  • Which specific outcomes are influenced (survival, dependency, social integration, mood, quality of life)?
  • Are there demonstrable cost-benefits for multidisciplinary care in MND?